In a world first, the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved trofolastat to detect cancerous lesions in men with prostate cancer.
Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, explores the key challenges in mesothelioma prevention, diagnosis and treatment.
October is dedicated to raising awareness for breast cancer. A recent study highlights the need for more education into the less common symptoms of breast cancer.
A recent study unveils alarming findings about women's cancer risk, indicating significant connections between the disease and exposure to certain endocrine-disrupting chemicals.
DeepMed has developed an AI oncology diagnostics system, DeepPathTM - LYDIA, to assist histopathologists in performing lymph node metastasis detection quickly and accurately.
Photodynamic therapy, using visible light with lower energy, causes fewer side effects when treating cancer, find Drs. Mary Potasek, Evgueni Parilov, and Karl Beeson, Co-founders of Simphotek, Inc.
Innovation for new healthcare technology has been funded toward treatments for Alzheimer’s, cancer and more, with support going to digital hubs and technology-assisted surgery.
Could cannabis for cancer become a reality in patient wards? Researchers find the plant can improve sleep, pain, and brain clarity, easing 'chemo brain'.
